Clinical Trial

A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health

Study acronym: A-MORE
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a 48-month observational, prospective, multicentre study. The overall aim of the study is to evaluate the long-term effectiveness of Elocta treatment on joint health in patients treated prophylactically with Elocta in a real-world setting.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2020-03-02; most recent amendment 2026-03-17.
Status change: Recruiting → Active, Not Recruiting 2022-02-09
Status change: Not Yet Recruiting → Recruiting 2020-04-03
Trial Details
NCT Number NCT04293523
Lead Sponsor Swedish Orphan Biovitrum
Conditions Hemophilia A
Enrollment 427 participants
Start Date 2020-03-30
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-19